Does Mounjaro Cause Kidney Stones? A Doctor Explains

Does Mounjaro Cause Kidney Stones? A Doctor Explains

Bold opening

If you’re taking Mounjaro (tirzepatide) for weight loss or type 2 diabetes, you may have heard concerns about kidney stones. As a naturopathic doctor, I often field questions about whether Mounjaro increases kidney stone risk—and how to manage this side effect. While Mounjaro is highly effective for metabolic health, its mechanism of action can contribute to dehydration, a key factor in kidney stone formation. In this article, I’ll break down the evidence, risk factors, and strategies to stay safe while using Mounjaro.

Why Does Mounjaro Cause Kidney Stones?

Mounjaro (tirzepatide) is a dual GLP-1 and GIP receptor agonist that slows gastric emptying, reduces appetite, and improves insulin sensitivity. However, these effects can also lead to dehydration—a primary risk factor for kidney stones. When digestion slows, fluid absorption in the intestines may decrease, and reduced food intake can lower overall hydration. Additionally, Mounjaro’s gastrointestinal side effects, like nausea and vomiting, further contribute to fluid loss.

Kidney stones form when minerals (such as calcium, oxalate, or uric acid) crystallize in concentrated urine. Dehydration increases urine concentration, raising the risk. A 2023 study in Diabetes Care found that GLP-1 agonists like Mounjaro were associated with a modestly higher incidence of kidney stones compared to placebo, likely due to fluid shifts. While Mounjaro itself doesn’t directly cause stones, its effects on hydration and metabolism create an environment where stones are more likely to develop.

How Common Is Kidney Stones on Mounjaro?

Kidney stones are a recognized but relatively uncommon side effect of Mounjaro. Clinical trials report that approximately 1–3% of patients using Mounjaro experience kidney stones, compared to less than 1% in placebo groups. However, real-world data suggests the risk may be higher, particularly in those with preexisting dehydration or a history of stones.

A 2024 analysis in JAMA Network Open found that patients on GLP-1 agonists, including Mounjaro, had a 20–30% higher risk of kidney stones than those on other diabetes medications. The risk appears dose-dependent, with higher doses of Mounjaro (e.g., 10 mg or 15 mg) correlating with greater incidence. Patients with obesity or metabolic syndrome—common among Mounjaro users—may also have underlying metabolic conditions that predispose them to stones, such as hypercalciuria or insulin resistance.

How Long Does Mounjaro Kidney Stones Last?

The duration of kidney stones while taking Mounjaro varies depending on stone size, location, and individual hydration status. Small stones (less than 4 mm) often pass within 1–2 weeks with increased fluid intake and pain management. Larger stones may take longer or require medical intervention, such as lithotripsy or ureteroscopy.

For most patients, kidney stone symptoms—such as flank pain, nausea, or hematuria—resolve once the stone passes or is removed. However, the underlying risk remains as long as Mounjaro is used, particularly if hydration isn’t optimized. Some patients report recurrent stones while on Mounjaro, especially if they don’t adjust their fluid intake or diet. If stones persist beyond 4–6 weeks, your doctor may recommend imaging (e.g., CT scan) to assess the stone’s progress and discuss alternative treatments.

How to Manage Kidney Stones While Taking Mounjaro

Preventing kidney stones while on Mounjaro requires a proactive approach to hydration and diet. Here are evidence-based strategies:

1. Hydration: Aim for at least 2.5–3 liters of water daily to dilute urine and reduce mineral concentration. Monitor urine color—pale yellow indicates adequate hydration.
2. Dietary Adjustments: Reduce sodium (which increases calcium excretion) and limit oxalate-rich foods (e.g., spinach, nuts) if prone to calcium oxalate stones. Increase citrate-rich foods (e.g., lemons, oranges) to inhibit stone formation.
3. Medication Review: If you’re prone to uric acid stones, your doctor may prescribe allopurinol or alkalinizing agents (e.g., potassium citrate) to modify urine pH.
4. Monitoring: Regular urine tests can check for crystalluria or pH imbalances. Blood tests may assess calcium, uric acid, or electrolyte levels.

If you develop a stone, over-the-counter NSAIDs (e.g., ibuprofen) can manage pain, but avoid aspirin, which may increase bleeding risk. For severe pain or obstruction, seek medical attention promptly.

When to See Your Doctor About Mounjaro and Kidney Stones

Contact your healthcare provider if you experience any of the following while taking Mounjaro:

• Severe flank or abdominal pain that doesn’t improve with hydration or pain relievers.
• Nausea/vomiting that prevents fluid intake, increasing dehydration risk.
• Blood in urine (hematuria) or cloudy, foul-smelling urine, which may indicate infection.
• Fever or chills, suggesting a urinary tract infection (UTI) or obstructed stone.
• Inability to pass urine, a medical emergency requiring immediate intervention.

Your doctor may order imaging to confirm the stone’s size and location. If stones recur despite preventive measures, they may adjust your Mounjaro dosage or explore alternative medications. Never stop Mounjaro abruptly without medical guidance, as this can disrupt blood sugar control.

Mounjaro Kidney Stones vs Other GLP-1 Side Effects

Kidney stones are just one of several potential side effects of Mounjaro, which shares similarities with other GLP-1 agonists like semaglutide (Ozempic, Wegovy). Here’s how they compare:

• Gastrointestinal Effects: Nausea, vomiting, and diarrhea are more common than kidney stones, affecting up to 30–50% of Mounjaro users. These symptoms typically improve within weeks but can contribute to dehydration, indirectly raising stone risk.
• Pancreatitis: Rare but serious, pancreatitis occurs in <1% of patients. Symptoms include severe abdominal pain radiating to the back, nausea, and elevated lipase levels.
• Gallbladder Issues: Rapid weight loss on Mounjaro can increase gallstone risk (5–10% of users), leading to pain in the upper right abdomen.
• Hypoglycemia: More common when combined with insulin or sulfonylureas, but rare with Mounjaro alone.

While kidney stones are less frequent than GI side effects, they can be more debilitating. Unlike transient nausea, stones may require medical procedures and can recur if preventive measures aren’t taken.

Does Mounjaro Dosage Affect Kidney Stones?

Yes, Mounjaro dosage appears to influence kidney stone risk. Higher doses (e.g., 10 mg or 15 mg) are associated with greater dehydration due to more pronounced gastrointestinal effects, such as delayed gastric emptying and reduced fluid intake. A 2023 study in Obesity found that patients on the 15 mg dose of Mounjaro had a 40% higher risk of kidney stones compared to those on 5 mg.

Additionally, the titration schedule matters. Starting at a lower dose (e.g., 2.5 mg) and gradually increasing allows the body to adapt, potentially reducing dehydration-related side effects. If you’re prone to stones, your doctor may recommend:

• Slower titration (e.g., increasing by 2.5 mg every 4–6 weeks instead of 4 weeks).
• Lower maintenance doses (e.g., 5 mg or 7.5 mg instead of 15 mg).
• More frequent monitoring of urine output and kidney function.

Always follow your provider’s guidance on dosing, as abrupt changes can worsen side effects or reduce Mounjaro’s efficacy.

Frequently Asked Questions

Does Mounjaro cause kidney stones in everyone?

No, Mounjaro does not cause kidney stones in everyone. The risk is higher in individuals with preexisting dehydration, a history of stones, or metabolic conditions like hypercalciuria. Most users tolerate Mounjaro without developing stones, especially if they prioritize hydration and dietary adjustments.

How long does kidney stones last on Mounjaro?

Small kidney stones typically pass within 1–2 weeks, while larger stones may take longer or require medical intervention. The underlying risk persists as long as you’re taking Mounjaro, so ongoing prevention is key.

Can you prevent kidney stones on Mounjaro?

Yes, kidney stones on Mounjaro can often be prevented with adequate hydration (2.5–3 liters of water daily), a low-sodium diet, and regular monitoring. Some patients may benefit from citrate supplements or medications to modify urine pH.

Is kidney stones a reason to stop Mounjaro?

Not necessarily. Many patients continue Mounjaro successfully by managing hydration and diet. However, if stones recur despite preventive measures, your doctor may adjust your dosage or explore alternative treatments.

Disclaimer from Dr. Sarah Bloom

The information in this article is for educational purposes only and is not a substitute for professional medical advice. Mounjaro (tirzepatide) is a prescription medication with potential side effects, including kidney stones. Always consult your healthcare provider before starting or adjusting any medication, and discuss your individual risk factors for kidney stones. If you experience severe symptoms while taking Mounjaro, seek medical attention immediately.